Arcellx, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ACLX Nasdaq 2830 www.arcellx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arcellx, Inc.

EHA 2025: Anito-cel to disrupt CAR-T market in multiple myeloma - Jun 17th, 2025 4:49 am
Arcellx Announces Its Participation at TD Cowen’s 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025 - May 21st, 2025 2:00 pm
Baron Discovery Fund Initiated a Position in Arcellx (ACLX) - May 20th, 2025 5:46 am
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma - May 14th, 2025 7:30 am
Here’s Why Arcellx (ACLX) Declined in Q1 - May 12th, 2025 6:25 am
Arcellx First Quarter 2025 Earnings: Misses Expectations - May 10th, 2025 6:18 am
Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates - May 8th, 2025 3:10 pm
Arcellx Provides First Quarter 2025 Financial Results and Business Highlights - May 8th, 2025 2:00 pm
Arcellx, Inc. (ACLX): Among Takeover Rumors Hedge Funds Are Buying - Apr 23rd, 2025 6:49 pm
Arcellx (ACLX): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential - Apr 11th, 2025 2:26 pm
Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors - Mar 20th, 2025 2:00 pm
We're Not Worried About Arcellx's (NASDAQ:ACLX) Cash Burn - Mar 3rd, 2025 3:34 am
Arcellx, Inc. (ACLX) Reports Q4 Loss, Lags Revenue Estimates - Feb 27th, 2025 5:05 pm
Arcellx Provides Fourth Quarter and Year-End 2024 Financial Results and Business Highlights - Feb 27th, 2025 2:00 pm
Arcellx to Participate at the TD Cowen 45th Annual Health Care Conference - Feb 26th, 2025 2:00 pm
Is Arcellx, Inc. (ACLX) An Oversold Biotech Stock to Buy Now? - Feb 24th, 2025 1:08 pm
Is Arcellx (ACLX) Poised to Capture Significant Market Share? - Feb 19th, 2025 8:20 am
Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock? - Jan 16th, 2025 6:33 am
Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock? - Jan 7th, 2025 2:14 am
Arcellx Stock Earns 82 Relative Strength Rating - Dec 27th, 2024 12:09 pm